OHSU receives $7.8 million NIH grant to develop first ultrasound to also deliver heart treatment

October 01, 2002

PORTLAND, Ore. -- Oregon Health & Science University is leading a new multicenter partnership that hopes to revolutionize the treatment of various forms of heart disease. Instead of using one device for ultrasound imaging of the heart and another to deliver treatment, this team plans to develop, for the first time, one miniaturized device that can do both. The team will create three different ultrasound devices that provide physicians a better look inside the heart than ever before during a procedure and deliver lifesaving therapies using the same device. The first heart condition to be addressed with be life-threatening irregular heart beats, known as arrhythmias. A condition affecting more than 2 million Americans.

The multicenter partnership, led by OHSU pediatric cardiologist David Sahn, M.D., a pioneer of echocardiography, was awarded a $7.8 million Bioengineering Partnership grant by the National Heart, Lung and Blood Institute of the National Institutes of Health. The unique team includes General Electric, University of Michigan, Pennsylvania State University, JOMED (EndoSonics) and Irvine Biomedical, Inc., all leaders in the development of biomedical equipment and cardiac catheterization. Sahn spent seven years forming this unique team and securing NIH funding. According to the NIH, the grant program was designed to encourage multidisciplinary teams of engineers, scientists and clinicians to solve medical and biological problems within a five - to10 - year timeframe.

"This feels great and is a real affirmation in recognizing that they believe in our vision," said Sahn, professor of pediatrics (cardiology) in the OHSU School of Medicine. "The most exciting element will be to integrate therapy with imaging, which we expect to be more efficient and improve patient outcomes."

The core of the five-year grant will be to develop three types of miniaturized ultrasound devices that can be inserted into the heart to provide treatment through a single catheter. Catheters act as long tunnels that allow physicians to access areas inside the body and provide treatment through tiny, pin-hole incisions, instead of invasive surgeries. Ultrasound devices, which use high-frequency sound waves to help physicians look inside the body, are currently inserted down a patient's throat during cardiac procedures to view the heart from behind while medications or impulses are administered via catheter. Producing an ultrasound image through a catheter already in the heart, rather than a patient's throat, can greatly improve patient outcomes while eliminating the need for anesthesia as well as reducing procedure duration, radiation exposure and cost. Other intracardiac catheter ultrasound systems have been developed, but they are expensive and are not reusable. Also, a separate catheter is needed in addition to the ultrasound device to provide additional testing and treatment of the heart condition.

Some of the most common cardiac catheter procedures use an electric charge to correct abnormal heart rhythms, which are prevalent in the elderly. More than one million of these procedures are performed each year, and that number will increase as the population ages. Sahn hopes the new ultrasound devices will allow these procedures to be performed in less time, at less cost and with less risk to the patient.

The first of the Sahn team's ultrasound devices will look like a hockey stick when fully extended, with ultrasound channels on the side of the tip. The device will include Doppler imaging, which tracks the movement of the heart's walls -- a vital tool in determining where an abnormal heart rhythm originates so those tissues can be removed as precisely as possible without damaging surrounding cells. All three devices will feature this type of imaging. This first device will offer a large two-dimensional (2-D) view of the heart, high ultrasound frequency and will be equipped to record abnormal electrical currents of the heart.

The second ultrasound device will retain the hockey-stick shape with the ultrasound channels positioned on the tip offering a smaller 2-D view, but a higher frequency ultrasound. This device will have the ability to not only detect and locate abnormal electrical currents in the heart, but also to treat them by burning the cells generating the abnormal charge.

The final device will take a revolutionary approach, with a ring of ultrasound channels inside the tip, surrounded by the electrical testing and treatment region. The ring configuration provides an extra opening where a separate smaller, more flexible treatment catheter can be inserted. This allows the physician to use moving 3-D ultrasound images inside the heart to guide and place the smaller catheter in intricate areas of the heart generating the arrhythmia. At the same time the physician can treat the abnormal heart rhythm more accurately using these detailed images.

Once developed, each device will be tested on pigs before undergoing human clinical trials. During the last three years of the study, the team plans to test the devices on 40-60 patients each year. The team hopes the devices' extremely small size will also make them an effective ultrasound tool for use in children and infants.

Sahn has worked on developing new ultrasound methods for children and newborns for almost 30 years. During that time, with NIH funding, he helped create one of the first high frequency minaturized ultrasound probes for imaging babies. Sahn hopes the ultrasound technology developed with this grant will be used for diagnosis and treatment of other conditions throughout the body for which a small probe for imaging and treatment might replace major surgery.
-end-
VISUALS: Photos of one of the proposed devices and of David Sahn, M.D., are available on the OHSU Web site at http://www.ohsu.edu/news/100102ultrasound.html.

Oregon Health & Science University

Related Catheter Articles from Brightsurf:

Catheter ablation linked to reduced risk of dementia in patients with atrial fibrillation
People with atrial fibrillation have a reduced risk of dementia if they undergo a procedure called catheter ablation to restore the normal rhythm of their heart, according to a new study published in the European Heart Journal that analyses over 27,000 patients with newly diagnosed atrial fibrillation out of a population of nearly a million people.

New female external catheter technology reduces CAUTI by 50%
Hospital-wide introduction of new female external catheter technology halved the number of catheter-associated urinary tract infections (CAUTIs) according to new research presented last week in Philadelphia at the 46th Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC).

Catheter ablation reduces dementia risk in A-Fib, heart disease patients more than medications
Study finds that performing catheter ablations on patients who suffer from both atrial fibrillation and carotid arterial disease reduces their risk of dementia and stroke compared to managing their care with medications.

Germ-fighting catheter coating may help prevent infections
In an innovation that may ultimately help to prevent deadly bloodstream infections, a team of biomedical engineers and infectious disease specialists at Brown University developed a coating to keep intravascular catheters from becoming a haven for harmful bacteria.

Annals of Internal Medicine embargoed news; Catheter ablation superior to standard drug
A meta-analysis of randomized controlled trials found that catheter ablation was superior to conventional drug therapy alone for patients with atrial fibrillation and heart failure.

Experts strongly recommend catheter based closure for 'hole in the heart' patients
A catheter based procedure to close a type of 'hole in the heart' followed by antiplatelet drugs (e.g. aspirin) should be recommended for patients under 60 years old, who have also had a stroke, say a panel of experts in The BMJ today.

Foleys aren't fun: Patient study shows catheter risks
A new study puts large-scale evidence behind what many hospital patients already know: Having a urinary catheter may help empty the bladder, but it can hurt, lead to urinary tract infections, or cause other issues in the hospital and beyond.

Catheter ablation better than pharmacological atrial fibrillation therapies
A new study revealed patients receiving radiofrequency catheter ablation compared to traditional drug therapies for atrial fibrillation (AF), a contributing factor to heart failure, had significantly lower hospitalization and mortality rates.

A self-propelled catheter with earthworm-like peristaltic motion
A research team of Toho University and Tokyo Institute of Technology has developed a mechanism of a self-propelled catheter capable of generating peristaltic motion just like an earthworm by applying pneumatic pressure inside only one tube.

New cardiac catheter combines light and ultrasound to measure plaques
Biomedical engineers at UC Davis have combined intravascular ultrasound with fluorescence lifetime imaging in a single catheter probe that can image the tiny arteries of a living heart.

Read More: Catheter News and Catheter Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.